Physician profile
Matthew J Allaway
NPI 1386750057
$20,627,081.20
in general payments reported to CMS, 2019-2025
26 companies · $21M in 2025
The $21M reported for 2025 was more than what 99% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $207 · 2021: $518 · 2022: $545 · 2023: $592 · 2024: $858 · 2025: $21M.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Acquisitions: $21M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $30K · Food and Beverage: $2,123 · Travel and Lodging: $1,450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Acquisitions | $20,592,418.17 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $29,650.00 |
| Food and Beverage | $2,123.12 |
| Travel and Lodging | $1,449.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $20,623,970.32 | 2021-2025 | General - Therapies, General - Oncology, General - Pelvic Organ Prolapse |
| Pfizer INC. | $476.75 | 2019-2025 | |
| Abbvie INC. | $456.47 | 2022-2025 | Botox, Lupron Depot |
| Astellas Pharma US INC | $412.85 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $363.93 | 2024-2025 | Orgovyx, Gemtesa |
| Laborie Medical Technologies Corp. | $222.69 | 2024-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Medtronic, INC. | $183.90 | 2021-2023 | Interstim |
| Allergan, INC. | $182.22 | 2020-2022 | |
| Teleflex LLC | $111.15 | 2023-2025 | Barrigel, Urolift |
| Dendreon Pharmaceuticals LLC | $100.64 | 2022-2024 | Provenge |
| Tolmar, INC. | $84.04 | 2023-2024 | |
| Axonics, INC. | $83.31 | 2021-2024 | Axonics |
| Koelis INC. | $66.37 | 2021 | |
| Janssen Biotech, INC. | $65.03 | 2019-2022 | |
| Intuitive Surgical, INC. | $55.89 | 2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus America INC. | $40.66 | 2023 | Itind System, Double-J |
| Bioprotect Medical, INC. | $32.89 | 2025 | Bioprotect Balloon Implant System |
| Neotract INC. | $28.50 | 2020 | |
| Antares Pharma, INC. | $27.60 | 2025 | Xyosted |
| Tolmar Pharmaceuticals, INC. | $24.91 | 2022 | |
| Calyxo, INC. | $18.81 | 2024 | Cvac Aspiration System |
| Endo USA, INC. | $17.47 | 2024 | Xiaflex |
| 180 Medical, INC. | $14.52 | 2019 | |
| Ambu INC. | $14.12 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $13.16 | 2020 | |
| Acerus Pharmaceuticals Corporation | $13.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Allaway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.